Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.04M P/E - EPS this Y 81.60% Ern Qtrly Grth -
Income -11.6M Forward P/E -0.40 EPS next Y 34.80% 50D Avg Chg -49.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -56.00%
Dividend N/A Price/Book 0.66 EPS next 5Y - 52W High Chg -82.00%
Recommedations 2.00 Quick Ratio 1.33 Shares Outstanding 2.55M 52W Low Chg 12.00%
Insider Own 0.07% ROA -140.03% Shares Float 2.55M Beta 0.24
Inst Own 5.59% ROE -366.18% Shares Shorted/Prior 16.35K/55.27K Price 0.76
Gross Margin - Profit Margin - Avg. Volume 132,850 Target Price 20.00
Oper. Margin - Earnings Date Nov 13 Volume 997,978 Change -22.53%
About Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.

Bio-Path Holdings, Inc. News
11/20/24 Bio-Path Holdings Inc (BPTH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial ...
11/15/24 Bio-Path: Q3 Earnings Snapshot
11/15/24 Bio-Path Holdings Reports Third Quarter 2024 Financial Results
11/08/24 Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024
10/10/24 Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
10/09/24 Bio-Path Holdings Inc (BPTH) Q2 2024 Earnings Call Highlights: Financial Improvements and ...
10/08/24 ACHR, BPTH, PLUG, REGRF:
10/08/24 Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
10/08/24 Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
09/16/24 Bio-Path Holdings Announces Publication in Biomedicines
09/04/24 Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 24
09/03/24 Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference
06:00 AM Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors
08/15/24 Bio-Path: Q2 Earnings Snapshot
08/15/24 Bio-Path Holdings Reports Second Quarter 2024 Financial Results
08/08/24 Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024
07/08/24 Bio-Path Holdings Provides Clinical Update and Expansion Plans
06/14/24 Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress
06/04/24 Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
06/04/24 Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
BPTH Chatroom

User Image DeezNuttz Posted - 1 hour ago

$BPTH

User Image Fast_Eddie_Felson Posted - 1 hour ago

$BPTH like clockwork there is your dump by the MM back to .75 This is a complete and total POS. Legal suit coming for you Neilsen and Morris.

User Image Fast_Eddie_Felson Posted - 1 hour ago

$BPTH one last thing: they never announced a PR that they regained compliance with the 2.5m min shareholder equity requirement. Given they can only raise a quarter of money a time, its also extremely likely that in the event they do not get an r/s, they WILL be forced to liquidate. Funny enough, ill take my chances in a sale of assets at a much higher price then than what any shareholder will be rewarded from a random pump. Also, watch for a big 40-50-60m day with no news like last year. That will be your exit liquidity, whatever you might gain from it.

User Image Fast_Eddie_Felson Posted - 1 hour ago

$BPTH voting NO will allow: 1) the MM will be forced to quit naked shorting this 2) make bpth management find a viable sale to an organization that is not determined to wreck their assets and sell it for pennies in liquidation 3) retail to not get cucked like always with lies from Doug Morris 4) maintains your dignity in doing the right thing They just did a r/s in Feb. it tanked 90% since then. Every piece of seemingly good news takes another 15-20% out of it. This company should be investigated and sued. If the resolution passes for r/s, I will see who wants to join in a class action suit. I will act as lead plaintiff and have already started my own prep for this.

User Image Fast_Eddie_Felson Posted - 2 hours ago

$BPTH daywinger you are a fucking idiot. I’m not the MM ya 🤡 . And yes this management team is only out to save their own skin , not advance any medicine. That’s why there is zero tute interest and they get in bed with shithole HF’s like armistice and intracoastal that issue warrants against the stock issuance. It has no where to go but be stuck within those bands. VOTE NO ON ALL PROPOSALS

User Image DayWinger Posted - 1 day ago

$BPTH no one should invest one dime in this stock until the SEC cleans house on those operating this market. I mean the Market Maker is Fast Freddy? WTH? It says a lot. Nothing about this stock is above board. And WTH is NASDAQ doing? It's like they hired a drug cartel to run things. BPTH is doing wonderful things with their research. They deserve to be funded, but not by this bunch!

User Image LiquidSquid Posted - 2 days ago

$BPTH I’ve never had a company call me to vote by proxy until yesterday. Reverse split incoming.

User Image MicsMugz Posted - 2 days ago

$BURU $BPTH

User Image Manipulation13F Posted - 3 days ago

$BPTH Not too far from $0.85 I wonder what bears think about that 😭😭😭💀💀💀💪💪💪💪💪👌

User Image DeezNuttz Posted - 3 days ago

$BPTH Like clock work…😆🤣

User Image Article_AI Posted - 5 days ago

$BPTH Bio-Path Holdings Expands DNAbilize® Technology Applications Bio-Path Holdings ( ($BPTH) ) has released its Q3 earnings. Here is a breakdown of the information Bio-Path Holdings presented to its investors. Bi... https://www.stck.pro/news/BPTH/93227751/

User Image Manipulation13F Posted - 6 days ago

$BPTH

User Image DeezNuttz Posted - 6 days ago

$BPTH

User Image Manipulation13F Posted - 6 days ago

$BPTH Soon people will be chasing lol

User Image DeezNuttz Posted - 6 days ago

$BPTH Got off while you can!!! 🤣😆🤣😆🤣😆🤣😆🤣

User Image DayWinger Posted - 6 days ago

$BPTH 30 thousand shares traded this morning and drove the market up 11%, then 2 shares were sold short and the price fell 10%, essentially killing the market. My 11 year old grandson would be a better market maker than this guy.

User Image DonCorleone77 Posted - 6 days ago

$BPTH Bio-Path reports Q3 EPS (70c) vs. ($6.36) last year "The third quarter was a particularly productive period for Bio-Path as we initiated our obesity program, which marks the first application of our DNAbilize platform beyond oncology and highlights its broad therapeutic potential," said Peter Nielsen, President and CEO. "Importantly, we continued to advance our oncology programs and were delighted with the swift enrollment of the third cohort in our Phase 1/1b clinical trial of BP1002 in venetoclax-resistant AML patients, which was ahead of our projected timelines. We also published an article highlighting the broad anti-tumor effect of BP1003 in numerous preclinical solid tumor models, including breast, ovarian, and pancreatic cancer, in the peer-reviewed journal, Biomedicines."

User Image d_risk Posted - 1 week ago

$BPTH - BIO-PATH HOLDINGS, INC. - 10Q - Updated Risk Factors Bio-Path Holdings faces Nasdaq delisting for not meeting stockholders equity requirements; appeal pending but outcome uncertain. #Risk https://d-risk.ai/BPTH/10-Q/2024-11-14

User Image DeezNuttz Posted - 1 week ago

$BPTH This will tank massively next week after earnings…

User Image DayWinger Posted - 1 week ago

$BPTH someone needs to tell the market maker that his job is to create a market, not kill the market!

User Image shavitmi Posted - 1 week ago

$BPTH $3 by march

User Image DeezNuttz Posted - 1 week ago

$BPTH This will be 30 cents in December…

User Image DeezNuttz Posted - 2 weeks ago

$BPTH

User Image DeezNuttz Posted - 2 weeks ago

$BPTH

User Image Kc24mo Posted - 2 weeks ago

$BPTH horrible

User Image HeatherW80 Posted - 2 weeks ago

$BNOX Crazy volume over here! $LIXT $BPTH

User Image EMartinson Posted - 2 weeks ago

$BPTH This will drop until earnings. Usually within a week after ER it will spike briefly. If you’re in this that’s your chance be ready.

User Image DeezNuttz Posted - 10/31/24

$BPTH Probably drop around 5 cents a week from here on out…30:1 RS 🤣😆🤣

User Image LiquidatingValue Posted - 10/31/24

$BPTH I guess we all knew it was a matter of time before it dropped below $1. I was surprised it stayed above a dollar for several days. No positive news means it's going to drop further.

User Image dale99 Posted - 10/31/24

$BPTH What is the date that it needs to achieve compliance?

Analyst Ratings
Roth MKM Buy Jul 8, 24
Roth MKM Buy Apr 18, 24
Roth MKM Buy Mar 27, 24